Overview

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Cyclooxygenase 2 Inhibitors